(Q44133720)

30 November 2017

Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence (English)

1 reference

30 November 2017

0 references

Xiong-Biao Wang

1

1 reference

30 November 2017

Maria Kakoulidou

2

1 reference

30 November 2017

Ricardo Giscombe

3

1 reference

30 November 2017

Qianhui Qiu

4

1 reference

30 November 2017

DeRen Huang

5

1 reference

30 November 2017

Ritva Pirskanen

6

1 reference

30 November 2017

Ann Kari Lefvert

7

1 reference

30 November 2017

language of work or name

1 reference

1 September 2002

1 reference

Journal of Neuroimmunology

30 November 2017

1 reference

30 November 2017

130

1 reference

30 November 2017

1-2

1 reference

30 November 2017

224-232

1 reference

CD28 function: a balance of costimulatory and regulatory signals

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

AU-rich elements: characterization and importance in mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Myasthenia gravis as a prototype autoimmune receptor disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Genetic association of Ctla-4 to myasthenia gravis with thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

NMR studies on functional structures of the AU-rich element-binding domains of Hu antigen C

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

CTLA-4: a negative regulator of autoimmune disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Identification of a translation inhibitory element (TIE) in the 3' untranslated region of the human interferon-beta mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Molecular basis of T cell inactivation by CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Structural analysis of CTLA-4 function in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

An AU-rich sequence in the 3'-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

A native soluble form of CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

STUDIES IN MYASTHENIA GRAVIS. 1. A CLINICAL STUDY OF 180 PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

CD4 alphabeta T lymphocytes express high levels of the T lymphocyte antigen CTLA-4 (CD152) in acute malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Control of T-cell activation by CD4+ CD25+ suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Analysis of the 5' and 3'UTRs in the post-transcriptional regulation of the interleukin-5 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Identification and characterization of proteins binding A + U-rich elements

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

Regulation of lipoprotein lipase translation by epinephrine in 3T3-L1 cells. Importance of the 3' untranslated region

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900228-X

7 January 2021

10.1016/S0165-5728(02)00228-X

Identifiers

DOI

1 reference

30 November 2017

1 reference